NASDAQ : AVAH

Aveanna Healthcare Holdings Inc. — Financial statements

Healthcare · Medical Care Facilities · United States

Last price 13.11 USD (Nov 2, 2026, 1:58 PM EST) · Market cap 2.86B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Aveanna Healthcare Holdings Inc. (AVAH) reported revenue of 2.60B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year February - January; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue2.60B2.43B2.02B1.90B1.79B1.68B
Cost of Revenue1.77B1.63B1.39B1.30B1.23B1.14B
Gross Profit833.88M804.28M635.54M595.43M553.23M542.40M
Selling, General & Admin522.48M514.86M477.00M471.70M477.30M410.25M
Other Operating Expenses-226.00K-54.00K-20.00K-259.00K1.95M-337.00K
Operating Expenses533.47M525.34M487.76M485.22M500.56M430.47M
Operating Income300.41M278.94M147.78M110.21M52.66M111.94M
Interest Expense-133.97M-151.97M-163.89M-170.25M-22.35M-55.74M
Interest & Investment Income5.49M2.83M498.00K327.00K679.00K253.00K
Other Non Operating Income (Expenses)16.38M7.35M31.89M25.66M3.64M-8.17M
EBT Excluding Unusual Items188.31M137.15M16.28M-34.05M34.63M48.28M
Merger & Restructuring Charges-14.76M-10.76M-2.70M824.00K-17.89M-30.35M
Impairment of Goodwill-105.14M-675.35M-117.70M
Gain (Loss) on Sale of Assets-1.86M-1.86M-3.21M-2.81M-3.50M-110.00K
Asset Writedown-1.92M-1.92M-5.29M-2.90M-1.70M
Other Unusual Items-21.86M-21.86M5.07M-13.70M
Pretax Income154.11M106.95M5.07M-139.00M-663.81M-113.58M
Income Tax Expense-120.65M-118.09M16.00M-4.47M-1.78M3.47M
Net Income274.76M225.03M-10.93M-134.52M-662.03M-117.04M
Net Income to Common274.76M225.03M-10.93M-134.52M-662.03M-117.04M
Shares Outstanding (Basic)212.72M203.53M192.89M189.96M185.55M170.62M
Shares Outstanding (Diluted)223.34M214.98M192.89M189.96M185.55M170.62M
EPS (Basic)1.291.11-0.06-0.71-3.57-0.69
EPS (Diluted)1.231.05-0.06-0.71-3.57-0.69
Free Cash Flow158.38M118.41M26.32M16.56M-60.41M-27.30M
Free Cash Flow Per Share0.710.550.140.09-0.33-0.16
Gross Margin32.04%33.05%31.39%31.42%30.95%32.31%
Operating Margin11.54%11.46%7.30%5.82%2.95%6.67%
Profit Margin10.56%9.25%-0.54%-7.10%-37.03%-6.97%
Free Cash Flow Margin6.08%4.87%1.30%0.87%-3.38%-1.63%
EBITDA311.23M289.08M157.36M122.09M72.08M131.29M
EBITDA Margin11.96%11.88%7.77%6.44%4.03%7.82%
D&A For EBITDA10.82M10.14M9.58M11.88M19.41M19.35M
EBIT300.41M278.94M147.78M110.21M52.66M111.94M
EBIT Margin11.54%11.46%7.30%5.82%2.95%6.67%
Effective Tax Rate315.48%

Balance sheet

Fiscal year February - January; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents97.20M193.26M84.29M43.94M19.22M30.49M
Trading Asset Securities12.03M3.90M
Cash & Short-Term Investments109.23M197.16M84.29M43.94M19.22M30.49M
Accounts Receivable340.99M316.12M277.66M245.81M225.63M225.29M
Receivables340.99M316.12M277.66M245.81M225.63M225.29M
Prepaid Expenses22.23M20.94M17.48M15.68M15.09M14.23M
Other Current Assets5.65M26.02M13.25M9.45M9.81M9.20M
Total Current Assets478.09M560.23M392.67M314.89M269.75M279.21M
Property, Plant & Equipment56.88M55.69M58.65M70.05M77.35M83.37M
Long-Term Investments4.80M38.28M53.48M81.75M
Goodwill1.28B1.12B1.05B1.05B1.16B1.84B
Other Intangible Assets99.82M92.56M89.57M94.01M95.86M102.85M
Long-Term Accounts Receivable38.34M28.81M22.43M21.32M22.86M25.53M
Long-Term Deferred Tax Assets136.76M137.14M
Long-Term Deferred Charges4.20M4.80M2.70M1.40M200.00K1.30M
Other Long-Term Assets16.26M7.31M4.55M3.30M4.29M6.53M
Total Assets2.11B2.01B1.66B1.61B1.71B2.33B
Accounts Payable32.41M31.97M36.44M30.13M44.62M52.62M
Accrued Expenses121.91M129.03M128.48M108.60M76.82M78.08M
Short-Term Debt165.00M171.18M173.90M158.96M146.18M125.11M
Current Portion of Long-Term Debt13.25M13.25M9.20M9.20M9.20M8.60M
Current Portion of Leases16.44M16.01M15.50M14.88M13.07M14.13M
Other Current Liabilities62.31M63.01M38.65M32.99M36.61M66.29M
Total Current Liabilities411.32M424.46M402.17M354.76M326.50M344.83M
Long-Term Debt1.28B1.29B1.27B1.28B1.28B1.24B
Long-Term Leases25.97M27.41M31.72M39.82M45.82M45.38M
Long-Term Deferred Tax Liabilities5.89M4.86M3.84M3.05M
Other Long-Term Liabilities96.45M78.67M74.05M64.64M58.69M61.30M
Total Liabilities1.82B1.82B1.79B1.74B1.72B1.70B
Common Stock2.18M2.11M1.93M1.91M1.89M1.85M
Additional Paid-In Capital1.36B1.35B1.26B1.24B1.23B1.21B
Retained Earnings-1.08B-1.16B-1.38B-1.37B-1.24B-574.68M
Comprehensive Income & Other730.00K730.00K1.46M2.13M2.13M2.13M
Shareholders' Equity288.01M195.19M-122.09M-127.44M-4.17M637.95M
Total Liabilities & Equity2.11B2.01B1.66B1.61B1.71B2.33B
Total Debt1.51B1.51B1.50B1.50B1.50B1.44B
Net Cash (Debt)-1.40B-1.32B-1.42B-1.46B-1.48B-1.40B
Net Cash Per Share-6.25-6.13-7.35-7.66-7.96-8.23
Filing Date Shares Outstanding218.22M217.51M195.09M192.38M188.86M184.73M
Total Common Shares Outstanding218.15M211.00M193.23M190.73M188.86M184.73M
Working Capital66.77M135.78M-9.50M-39.87M-56.75M-65.62M
Book Value Per Share1.320.93-0.63-0.67-0.023.45
Tangible Book Value-1.09B-1.02B-1.27B-1.28B-1.26B-1.30B
Tangible Book Value Per Share-4.99-4.83-6.55-6.69-6.67-7.04
Machinery84.83M75.96M70.00M62.67M56.59M
Construction In Progress126.00K231.00K544.00K728.00K1.48M
Leasehold Improvements21.98M21.81M20.90M20.07M19.43M

Cash flow statement

Fiscal year February - January; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income274.76M225.03M-10.93M-134.52M-662.03M-117.04M
Depreciation & Amortization10.82M10.14M9.58M28.20M36.92M34.19M
Other Amortization4.85M6.25M6.66M7.08M9.68M9.90M
Loss (Gain) From Sale of Assets1.67M1.86M3.21M2.81M3.50M110.00K
Asset Writedown & Restructuring Costs15.00K15.00K2.09M105.14M675.35M117.70M
Loss (Gain) From Sale of Investments13.30M29.65M15.20M28.27M-85.37M
Stock-Based Compensation17.19M25.06M17.46M13.16M15.89M14.43M
Other Operating Activities-119.52M-119.50M19.33M-4.06M-115.00K698.00K
Change in Accounts Receivable-12.00M-30.22M-28.64M-15.32M-3.23M-8.81M
Change in Accounts Payable-14.33M-6.23M6.45M-13.92M-3.92M-11.70M
Change in Other Net Operating Assets-8.56M-16.21M-7.78M5.84M-35.07M-50.82M
Operating Cash Flow168.20M125.86M32.64M22.67M-48.40M-11.35M
Capital Expenditures-9.81M-7.45M-6.32M-6.12M-12.01M-15.95M
Cash Acquisitions-169.44M-14.85M-2.01M-666.91M
Divestitures460.00K
Sale (Purchase) of Intangibles-2.68M
Other Investing Activities-4.63M-11.72M1.03M
Investing Cash Flow-183.89M-22.30M-6.32M-8.79M-25.29M-681.83M
Short-Term Debt Issued25.00M70.00M15.00M2.46M
Long-Term Debt Issued1.32B99.70M1.47B
Total Debt Issued1.32B1.32B25.00M70.00M114.70M1.48B
Short-Term Debt Repaid-12.64M-17.89M-64.82M-15.00M-31.90M
Long-Term Debt Repaid-1.31B-9.47M-9.87M-39.55M-1.31B
Total Debt Repaid-1.32B-1.32B-27.36M-74.68M-54.55M-1.34B
Net Debt Issued (Repaid)-3.35M-3.76M-2.36M-4.68M60.15M132.15M
Issuance of Common Stock7.80M6.52M3.09M945.00K4.01M480.98M
Repurchase of Common Stock-478.00K-6.29M
Other Financing Activities8.18M8.94M13.30M14.59M-1.74M-26.80M
Financing Cash Flow12.15M5.41M14.03M10.85M62.42M586.33M
Net Cash Flow-3.54M108.97M40.35M24.73M-11.27M-106.86M
Free Cash Flow158.38M118.41M26.32M16.56M-60.41M-27.30M
Free Cash Flow Margin6.08%4.87%1.30%0.87%-3.38%-1.63%
Free Cash Flow Per Share0.710.550.140.09-0.33-0.16
Levered Free Cash Flow103.81M79.12M11.72M-4.62M28.68M-5.90M
Unlevered Free Cash Flow183.09M168.25M108.69M96.60M34.87M20.24M
Cash Interest Paid128.79M143.10M152.51M137.85M102.53M58.96M
Cash Income Tax Paid28.02M30.77M5.71M1.14M1.59M5.28M
Change in Working Capital-34.89M-52.66M-29.97M-23.40M-42.22M-71.33M

Ratios

Fiscal year February - January; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization2.86B1.69B900.43M511.16M145.02M1.36B
Enterprise Value4.26B3.05B2.33B1.96B1.57B2.16B
Last Close Price13.168.084.662.680.787.40
PE Ratio10.637.50
Forward PE15.1614.8277.5444.0444.0414.30
PS Ratio1.100.690.450.270.080.81
PB Ratio9.978.65-7.38-4.01-34.732.14
P/FCF Ratio18.1314.2634.2130.88
P/OCF Ratio17.0713.4127.5922.55
PEG Ratio0.720.740.740.740.740.36
EV/Sales Ratio1.641.251.151.030.881.28
EV/EBITDA Ratio13.7110.5414.7816.0621.7916.43
EV/EBIT Ratio14.2110.9215.7317.8029.8219.27
EV/FCF Ratio26.9525.7288.34118.46
Debt / Equity Ratio5.237.76-12.30-11.76-358.172.25
Debt / EBITDA Ratio4.444.788.119.9515.119.21
Debt / FCF Ratio9.5012.7957.0790.55
Net Debt / Equity Ratio4.856.75-11.61-11.42-353.562.20
Net Debt / EBITDA Ratio4.494.569.0111.9220.4810.70
Net Debt / FCF Ratio8.8111.1253.8787.90-24.43-51.45
Asset Turnover1.341.321.241.140.880.80
Quick Ratio1.091.210.900.820.750.74
Current Ratio1.161.320.980.890.830.81
Return on Equity (ROE)198.57%615.68%-208.92%-25.86%
Return on Assets (ROA)9.69%9.49%5.64%4.14%1.63%3.35%
Return on Invested Capital (ROIC)18.60%20.11%-25.28%8.34%3.07%6.52%
Return on Capital Employed (ROCE)17.70%17.60%11.70%8.80%3.80%5.60%
Earnings Yield9.40%13.33%-1.21%-26.32%-456.52%-8.59%
FCF Yield5.52%7.02%2.92%3.24%-41.66%-2.00%
Buyback Yield / Dilution-12.72%-11.45%-1.55%-2.37%-8.75%-21.04%